(Updates with market moves at the end of the day.) Stocks on Wall Street ended Monday's choppy tr

US benchmark equity indexes were mostly higher intraday Monday as key chipmakers advanced, while tra

Quarterly results of an initial batch of S&P 500 companies show that earnings growth so far is track

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

US equity futures were higher pre-bell Monday as traders monitored the latest developments in the Mi

The benchmark US stock measures were pointing higher before the opening bell Monday as investors awa

Wall Street futures pointed moderately higher pre-bell Monday as traders assessed values after recen

Today Earnings (a.m.): Domino’s Pizza, AMC Entertainment Holdings Earnings (p.m.): Steel Dynamics Economic data: U.S. leading economic indicators report for June Tomorrow Earnings: General Motors, ...

It’s a heavy earnings week, with results also coming in from Halliburton, 3M, AT&T, Blackstone, and more. On the economic front, we’ll see data on jobs, new-home sales, and industry purchasing activity.

Earlier this week, Philip Morris International announced that the U.S. FDA had authorized commercialization of its ZYN smoke-free nicotine pouches as modified risk tobacco products, recognizing that switching completely from cigarettes to ZYN reduces exposure to harmful chemicals linked to major smoking-related diseases. This decision makes ZYN the first and only nicotine pouch brand with modified risk status in the U.S., giving Philip Morris a distinct regulatory and scientific edge in the...

Philip Morris International (PM) is back in focus after the U.S. Food and Drug Administration authorized its ZYN smoke free nicotine pouches as modified risk tobacco products, marking the first such authorization for the nicotine pouch category. See our latest analysis for Philip Morris International. Philip Morris International’s recent FDA milestone comes on top of strong share price momentum, with a 22.30% 90 day share price return and a 147.74% five year total shareholder return,...

Philip Morris is poised for Q2 sales and earnings growth as smoke-free momentum, pricing power and productivity offset Japan and regulatory headwinds.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

The companies you own inside this consumer staples fund are collectively signaling stronger profits are on the way.

Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.